Related Experiment Video
Updated: Aug 9, 2026
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
Published on: July 1, 2021
Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch
Paul Cohen1, Julia D Levy2, Yingying Zhang2
1Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Abstract:
A clear relationship exists between visceral obesity and type 2 diabetes, whereas subcutaneous obesity is comparatively benign. Here, we show that adipocyte-specific deletion of the coregulatory protein PRDM16 caused minimal effects on classical brown fat but markedly inhibited beige adipocyte function in subcutaneous fat following cold exposure or β3-agonist treatment. These animals developed obesity on a high-fat diet, with severe insulin resistance and hepatic steatosis. They also showed altered fat distribution with markedly increased subcutaneous adiposity. Subcutaneous adipose tissue in mutant mice acquired many key properties of visceral fat, including decreased thermogenic and increased inflammatory gene expression and increased macrophage accumulation. Transplantation of subcutaneous fat into mice with diet-induced obesity showed a loss of metabolic benefit when tissues were derived from PRDM16 mutant animals. These findings indicate that PRDM16 and beige adipocytes are required for the "browning" of white fat and the healthful effects of subcutaneous adipose tissue.
Insights
The coregulatory protein PRDM16 is essential for beige adipocyte function, which protects against obesity and insulin resistance. Loss of PRDM16 converts beneficial subcutaneous fat into harmful visceral fat.
Area of Science:
- Metabolic disease
- Adipose tissue biology
- Obesity research
Background:
- Visceral obesity is strongly linked to type 2 diabetes, while subcutaneous obesity is generally considered less harmful.
- The role of specific proteins in regulating fat tissue function and metabolic health is an area of active investigation.
Purpose of the Study:
- To investigate the function of the coregulatory protein PRDM16 in adipocytes.
- To determine the impact of PRDM16 deletion on beige adipocyte activity and overall metabolic health.
Main Methods:
- Generated mice with adipocyte-specific deletion of PRDM16.
- Administered cold exposure and beta-3 adrenergic agonist to stimulate beige adipocyte function.
- Assessed metabolic parameters including obesity, insulin resistance, and hepatic steatosis on a high-fat diet.
- Performed fat tissue transplantation experiments.
Main Results:
- PRDM16 deletion inhibited beige adipocyte function in subcutaneous fat but had minimal effects on classical brown fat.
- Mice lacking PRDM16 in adipocytes developed obesity, severe insulin resistance, and hepatic steatosis when fed a high-fat diet.
- Subcutaneous adipose tissue in mutant mice exhibited visceral fat characteristics, including altered gene expression and increased macrophage accumulation.
- Transplantation of subcutaneous fat from PRDM16 mutant mice failed to provide metabolic benefits.
Conclusions:
- PRDM16 is crucial for the "browning" of white adipose tissue and the beneficial metabolic effects of subcutaneous fat.
- Beige adipocytes, regulated by PRDM16, play a vital role in maintaining metabolic health and preventing obesity-related diseases.
More Related Videos
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inborn Errors of Metabolism
Diabetic Retinopathy
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology